Faga Daniel's Form 4 filing
Anaptysbio, IncANAB · filed Mar 26, 2024
- Accession no.
- 0001415889-24-009164
- Filed
- Mar 26, 2024
- Trade date
- Mar 22-26, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $3.39M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Faga DanielCIK 0001673528 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 22, 2024 | Common Stock | SSaleDisposed | −145,940 | $22.78 | −$3,324,513.2 | 752,087 | Direct | |
| Mar 25, 2024 | Common Stock | SSaleDisposed | −3,000 | $21.42 | −$64,260 | 749,087 | Direct | |
| Mar 26, 2024 | Common Stock | FTax withholdingDisposed | −347,441 | $21.60 | −$7,504,725.6 | 401,646 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.